Skip to content
10-Q

Quarterly Report

ZS Pharma, Inc.

0001193125-15-371791

← back to feed
Filed
Nov 9, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 3, 2015 25.27M sh
Capex Q3 2015 · Sep 30, 2015 $6.32M
Capex Q3 2015 · Sep 30, 2014 $5.75M
Long Term Debt Q3 2015 · Sep 30, 2015 $7.67M
Long Term Debt Q3 2015 · Dec 31, 2014 $9.96M
Short Term Debt Q3 2015 · Sep 30, 2015 $2.5M
Short Term Investments Q3 2015 · Sep 30, 2015 $142.6M
Short Term Investments Q3 2015 · Dec 31, 2014 $54.88M
Cash And Equivalents Q3 2015 · Sep 30, 2015 $64.35M
Cash And Equivalents Q3 2015 · Dec 31, 2014 $47.4M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $121.53M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $9.17M
Stockholders Equity Q3 2015 · Sep 30, 2015 $199.77M
Stockholders Equity Q3 2015 · Dec 31, 2014 $96.77M
Current Liabilities Q3 2015 · Sep 30, 2015 $20.57M
Current Liabilities Q3 2015 · Dec 31, 2014 $9.14M
Total Liabilities Q3 2015 · Sep 30, 2015 $30.77M
Total Liabilities Q3 2015 · Dec 31, 2014 $19.39M
Current Assets Q3 2015 · Sep 30, 2015 $210.74M
Current Assets Q3 2015 · Dec 31, 2014 $103.26M
Total Assets Q3 2015 · Sep 30, 2015 $230.54M
Total Assets Q3 2015 · Dec 31, 2014 $116.16M
Sga Expense Q3 2015 · Sep 30, 2015 $16.84M
Sga Expense Q3 2015 · Sep 30, 2015 $38.41M
Sga Expense Q3 2015 · Sep 30, 2014 $4.08M
Sga Expense Q3 2015 · Sep 30, 2014 $9.38M
Rd Expense Q3 2015 · Sep 30, 2015 $18.4M
Rd Expense Q3 2015 · Sep 30, 2015 $51.01M
Rd Expense restated Q3 2015 · Sep 30, 2014 $12.54M
Rd Expense restated Q3 2015 · Sep 30, 2014 $31.04M
Net Income Q3 2015 · Sep 30, 2015 −$35.35M
Net Income Q3 2015 · Sep 30, 2015 −$89.9M
Net Income Q3 2015 · Sep 30, 2014 −$16.86M
Net Income Q3 2015 · Sep 30, 2014 −$44.04M
Operating Income Q3 2015 · Sep 30, 2015 −$35.25M
Operating Income Q3 2015 · Sep 30, 2015 −$89.42M
Operating Income Q3 2015 · Sep 30, 2014 −$16.62M
Operating Income Q3 2015 · Sep 30, 2014 −$40.43M